The likelihood to develop stress-related psychiatric disorders in response to childhood trauma exposure may be moderated by the individual’s genetic predisposition (Manuck and McCaffery, 2014). One of the genetic variants reported to alter the risk for psychiatric disorders following childhood trauma is a functional variant in FKBP5, a gene encoding a co-chaperone of the glucocorticoid receptor (GR). FKBP5 is strongly induced following stress exposure via binding of activated GR to a number of intronic and promoter GR response elements (GREs). The protein itself then binds to the GR complex, reduces the affinity of GR to cortisol and decreases translocation of the GR to the nucleus, providing an ultrashort negative feedback for GR activation on the genomic and protein level (Zannas and Binder, 2014). We have identified a functional polymorphism in close proximity of a GRE in intron 2 of FKBP5, which alters the extent of mRNA and protein induction following GR activation, likely by an altered 3D conformation. This results in a variable interaction of the intron 2 GRE with the transcription start site, leading to increased or reduced mRNA induction, respectively (Klengel et al, 2013). Individuals carrying the allele associated with stronger FKBP5 mRNA induction show GR resistance, prolonged cortisol response following stress, altered activation of brain regions important for threat response, such as the amygdala, and increased risk to a number of psychiatric disorders including major depression and post-traumatic stress disorder when exposed to childhood trauma. Interestingly, while the genetic effects on the physiological stress response are seen in adults, no interaction of adult trauma with this genotype on psychiatric risk is observed, suggesting an additional mechanism that explains the FKBP5 × childhood trauma interaction. In fact, we could show that exposure to childhood trauma leads to allele-specific epigenetic changes with a decrease in DNA methylation in a second GRE located in intron 7 of the gene, but only in carriers of the risk allele. This demethylation further de-represses FKBP5 induction following GR exposure and is likely mediated by the genetically determined increase in cortisol response following stress (Klengel et al, 2013) (Figure 1). Indeed, direct GR activation with a selective agonist in a neuronal progenitor cell line leads to a demethylation in exactly the same CG dinucleotides (CpGs) that are shown to be less methylated in DNA from peripheral blood in trauma-exposed risk allele carriers. These CpGs are located either within or between GR consensus binding site sequences, while more proximal CpGs are unaffected. We thus speculate that the demethylation is an active demethylation, induced by GR binding. Such active demethylation at GREs has been described before (Kress et al, 2006) and, although not directly shown, hydroxymethylation could be an intermediate step in this active transcription factor binding-induced demethylation (Bhutani et al, 2011), a process that has been described for other transcription factors as well (Feldmann et al, 2013). On a more general level, any genetic variant that alters binding of stress-induced transcription factors may thus lead to local differences in subsequent epigenetic changes. Thereby, allele-specific epigenetic modifications can contribute to gene × environment interactions, leading to long-term effects of stress on endocrine levels, brain activity, and the risk to develop psychiatric disorders.
FUNDING AND DISCLOSURE
Funding for the research presented here was provided by the European Research Council grant no. 281338, the National Institute of Mental Health grants (MH071538 and MH58922), the Max Planck Society, and the Behrens Weise Stiftung. TK is supported by an EMBO long-term fellowship (ALTF 1153-2013). EBB is holding a patent for the use of FKBP5 in antidepressant therapy (WO 2005/054500: FKBP5: a novel target for antidepressant therapy) and received an honorarium from GSK.
References
Bhutani N, Burns DM, Blau HM (2011). DNA demethylation dynamics. Cell 146: 866–872.
Feldmann A, Ivanek R, Murr R, Gaidatzis D, Burger L, Schuebeler D (2013). Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet 9: e1003994.
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al (2013). Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16: 33–41.
Kress C, Thomassin H, Grange T (2006). Active cytosine demethylation triggered by a nuclear receptor involves DNA strand breaks. Proc Natl Acad Sci USA 103: 11112–11117.
Manuck SB, McCaffery JM (2014). Gene-environment interaction. In: Fiske ST, (ed). Annual Review of Psychology, Vol 65. Annual Reviews: Palo Alto, CA. pp 41–70.
Zannas AS, Binder EB (2014). Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. Genes Brain Behav 13: 25–37.
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Klengel, T., Binder, E. FKBP5 Allele-Specific Epigenetic Modification in Gene by Environment Interaction. Neuropsychopharmacol 40, 244–246 (2015). https://doi.org/10.1038/npp.2014.208
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2014.208
This article is cited by
-
Genetic association of FKBP5 with trait resilience in Korean male patients with alcohol use disorder
Scientific Reports (2021)
-
Three-way interaction effects of early life stress, positive parenting and FKBP5 in the development of depressive symptoms in a general population
Journal of Neural Transmission (2021)
-
Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus
Clinical Epigenetics (2019)
-
Umwelt und Epigenetik
Der Nervenarzt (2019)
-
Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5
Clinical Epigenetics (2018)